So what happened to alosetron?
Hyams
J S
JS
D002243:Carbolines / Q000009:adverse effects* / Q000627:therapeutic use; D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D012449:Safety; D012702:Serotonin Antagonists / Q000009:adverse effects* / Q000627:therapeutic use
D002243:Carbolines; D005765:Gastrointestinal Agents; D012702:Serotonin Antagonists; C090840:alosetron